Gossamer Bio, Inc. (GOSS) Form 8-K — Jul 14, 2026
Gossamer Bio stockholders approved a Charter Amendment increasing the number of authorized shares of common stock from 700 million to 4 billion. This increase supports the issuance of shares related to the recently closed Exchange Offer involving new convertible notes and warrants, as well as the Restated 2019 Incentive Award Plan. Investors also authorized a series of 30 alternate amendments to the Charter to effect a reverse stock split and a corresponding reduction in authorized shares. This approval grants the Board flexibility to implement a reverse split to maintain Nasdaq listing compliance if the stock price remains low.
Key figures
- Authorized Shares New
- 4000000000
- Reverse Split Amendments
- 30
- Authorized Shares Previous
- 700000000
Price after filing
Close on the filing date to close N calendar days later (from $0.14). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.